ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | -75.0% | 500 | -75.0% | 0.00% | – |
Q4 2016 | $12,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2016 | $15,000 | -11.8% | 2,000 | 0.0% | 0.00% | – |
Q2 2016 | $17,000 | +30.8% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $13,000 | -23.5% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $17,000 | +240.0% | 2,000 | +100.0% | 0.00% | – |
Q3 2015 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2015 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | +100.0% | 1,000 | +171.0% | 0.00% | – |
Q3 2014 | $3,000 | – | 369 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 366,401 | $2,374,000 | 2.07% |
Private Portfolio Partners LLC | 67,400 | $436,752 | 0.12% |
Knoll Capital Management, LLC | 20,000 | $130,000 | 0.08% |
ETF MANAGERS GROUP, LLC | 94,493 | $612,000 | 0.02% |
Virtu Financial LLC | 21,526 | $139,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 21,904 | $142,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $36,000 | 0.01% |
Walleye Capital LLC | 78,418 | $508,000 | 0.01% |
Jump Financial, LLC | 36,100 | $234,000 | 0.01% |
Plante Moran Financial Advisors, LLC | 7,911 | $51,000 | 0.01% |